FDA seeks USPTO action to tackle patent thicketing

IP policies proposed by the Department of Health miss the mark, but discussions between the two agencies get closer to the nub of the issue

FDA seeks USPTO action to tackle patent thicketing
Levelling the playing field in ITC patent cases by identifying redesigns to a set deadline
20 Sep 2021

Levelling the playing field in ITC patent cases by identifying redesigns to a set deadline

Recent respondent tactics and how ALJ’s have reacted to them have disadvantaged complainants – but this is a problem that can be overcome

Bausch Health pays $300 million to settle pay-for-delay class action
17 Sep 2021

Bausch Health pays $300 million to settle pay-for-delay class action

The agreement demonstrates the huge sums at stake in reverse payment disputes


View all
16 Sep 2021

CAFC decision highlights continued danger of inequitable conduct rulings

The Federal Circuit’s judgment in a recent pharma patent case is a stark reminder that IP professionals must remain vigilant Read more

15 Sep 2021

Uber and Cruise band together for launch of new auto IP group

The Auto Transportation Association will bring together executives in transportation companies to communicate and collaborate on patent-related issues Read more

14 Sep 2021

Open source is fundamental to crypto, so we must protect it, says Square counsel

In an exclusive interview, Max Sills explains why the firm has joined the OIN and provides an update on the Crypto Open Patent Alliance Read more

14 Sep 2021

New Humira decision changes venue selection playbook for US biosimilar patent disputes

A recent court ruling suggests that plaintiffs will enjoy more latitude on venue selection when suing biologics imitators Read more


View all
13 Sep 2021

How to be an IP leader

New IAM special report focuses on the men and women at the top of the pile who set the strategies and do the deals that drive the market forward Read more

6 Sep 2021

Drafting AI patent applications for success at the EPO – eligibility and claim formulation

Co-published – There are different types of AI inventions and patent claims should be structured differently for each type in order to comply with the office’s eligibility requirements and obtain commercially relevant rights Read more

31 Aug 2021

The world’s leading IP strategists named

The 2021 edition of the IAM Strategy 300 has been published and identifies gamechangers working inside corporations, aggregators, service providers, research institutions and universities, among others Read more

25 Aug 2021

IAM parent company acquires market-leading US patent litigation data and analytics firm

Austin-based Docket Navigator - which also covers trademarks, antitrust and other practice areas - becomes a Law Business Research company Read more


View all
10 Sep 2021

With little overseas patent footprint, a Chinese battery champion faces its first litigation

A Zhuhai company that has grown to be the world’s second largest supplier of laptop and tablet batteries faces new US patent claims as it prepares to go public Read more

9 Sep 2021

Biologics patent thicketing problem getting worse, says Fresenius’ IP chief

The growing IP estates of new drugs such as Keytruda give an idea of the mounting challenges for US biosimilars, claims Rachel Moodie Read more

8 Sep 2021

Assessing the reasonableness of 5G headline royalty rates

The Long Read: The licensing fees Nokia, Ericsson and InterDigital have set for the latest mobility standard materially exceed those they were able to achieve in their 4G programmes, write Ankura's Michael J Lasinski, Philip W Kline and Alejandra P Loaiza-Delgado Read more

7 Sep 2021

English Court of Appeal brings sufficiency test into line with EPO case law

A recent UK judgment is good news for owners of patents claiming large numbers of compounds Read more


View all
12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

30 Jan 2019

Apple v Qualcomm is the global patent fight for our times

Why Qualcomm’s winning of an injunction in China against Apple is another sign that the patent market is drifting inexorably eastwards. With the country’s answer to the Court of Appeals for the Federal Circuit opening at the start of this year, rights holders have even more reason to turn to Chinese courts. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more